N-(2-((5-chloro-2-((2-methoxy-4-(2-oxopiperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acetamide

ID: ALA4572661

PubChem CID: 155564024

Max Phase: Preclinical

Molecular Formula: C24H25ClN6O3

Molecular Weight: 480.96

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCCCC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1

Standard InChI:  InChI=1S/C24H25ClN6O3/c1-15(32)27-18-7-3-4-8-19(18)28-23-17(25)14-26-24(30-23)29-20-11-10-16(13-21(20)34-2)31-12-6-5-9-22(31)33/h3-4,7-8,10-11,13-14H,5-6,9,12H2,1-2H3,(H,27,32)(H2,26,28,29,30)

Standard InChI Key:  POTGZPRTWMEZJA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   16.7469   -9.5628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7457  -10.3823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4538  -10.7913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1634  -10.3818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1606   -9.5592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4520   -9.1539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4536  -11.6084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7458  -12.0169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7456  -12.8341    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0382  -11.6081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8718  -10.7893    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5789  -10.3796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2839  -10.7875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9905  -10.3785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9896   -9.5604    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2763   -9.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5726   -9.5645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8623   -9.1605    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   21.6986  -10.7863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4059  -10.3770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1130  -10.7864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8198  -10.3777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8194   -9.5597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1063   -9.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4024   -9.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1128  -11.6036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8204  -12.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5261   -9.1494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2302   -9.5585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9348   -9.1517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9371   -8.3342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2286   -7.9251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5178   -8.3336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2291  -10.3757    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 14 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 21 26  1  0
 26 27  1  0
 23 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 29 34  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4572661

    ---

Associated Targets(Human)

NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 480.96Molecular Weight (Monoisotopic): 480.1677AlogP: 5.10#Rotatable Bonds: 7
Polar Surface Area: 108.48Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.70CX Basic pKa: 3.19CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.43Np Likeness Score: -1.56

References

1. Lei H, Jia F, Cao M, Wang J, Guo M, Zhu M, Zuo D, Zhai X..  (2019)  An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects.,  27  (20): [PMID:31492532] [10.1016/j.bmc.2019.115051]

Source